share_log

The Analyst Verdict: Ionis Pharmaceuticals In The Eyes Of 6 Experts

The Analyst Verdict: Ionis Pharmaceuticals In The Eyes Of 6 Experts

分析師觀點:在6位專家眼中的Ionis Pharmaceuticals
Benzinga ·  12/20 22:01
6 analysts have expressed a variety of opinions on Ionis Pharmaceuticals (NASDAQ:IONS) over the past quarter, offering a diverse set of opinions from bullish to bearish.
在過去的一個季度中,6位分析師對Ionis Pharmaceuticals(納斯達克:IONS)表達了不同的觀點,從看好到看淡,意見多樣。
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
在下面的表格中,您將找到他們最近評級的摘要,揭示了過去30天情緒的變化,並與前幾個月進行了比較。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $65.67, a high estimate of $77.00, and a low estimate of $60.00. A decline of 3.18% from the prior average price target is evident in the current average.
經過分析師分析,12個月的價格目標提供了洞見,平均目標爲65.67美元,最高估計爲77.00美元,最低估計爲60.00美元。從之前的平均價格目標來看,目前的平均目標明顯下降了3.18%。
Investigating Analyst Ratings: An Elaborate Study
分析師評級的調查:一項詳盡的研究
A comprehensive...
關於...

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論